Seeley, Randy J. http://orcid.org/0000-0002-3721-5625
Rhodes, Christopher J. http://orcid.org/0000-0002-7450-1110
Article History
First Online: 22 August 2022
Competing interests
: R.J.S. receives research support from AstraZeneca, Novo Nordisk and Fractyl. R.J.S. has served as a paid consultant for Novo Nordisk, Scohia, CinRx, ShouTi Pharma and Fractyl. R.J.S. has equity in Calibrate and Rewind. This work was supported by NIH grants to R.J.S. P01DK117821 and P30DK089503. C.J.R. is an employee of AstraZeneca and owns AstraZeneca stock.